rss
Thorax 54:1087-1092 doi:10.1136/thx.54.12.1087
  • Original article

Review of therapeutically equivalent alternatives to short acting β2 adrenoceptor agonists delivered via chlorofluorocarbon-containing inhalers

Table 3

Therapeutically equivalent alternatives to short acting β2 adrenoceptor agonists delivered via CFC-MDIs

Alternatives to salbutamol CFC-MDI
(1) Evidence for equal potency and efficacy:
 Salbutamol HFC-MDI (Airomir)
 Salbutamol HFC-MDI (Ventolin Evohaler)
 Salbutamol Rotahaler
 Salbutamol Clickhaler
(2) Evidence for single doses being equally efficacious:
 Salbutamol 200 μg via CFC-MDI
 Salbutamol Accuhaler, 200 μg
 Salbutamol Diskhaler, 400 μg
Alternatives to terbutaline CFC-MDI
(1) Evidence for equal potency and efficacy:
 Terbutaline Turbohaler

This Article

  1. Abstract
  2. Full text
  3. PDF

Free sample
This recent issue is free to all users to allow everyone the opportunity to see the full scope and typical content of Thorax.
View free sample issue >>

Don't forget to sign up for content alerts so you keep up to date with all the articles as they are published.